Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.

Gynecol Oncol · 2019 · PMC6613945 · PMID 30470581

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was a small association of very early discontinuation with pre-treatment ascites and pre-treatment bulky disease, although these associations did not reach statistical significance, likely secondary to small sample numbers.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.